Departamento de Quimica Organica, Universidade de Vigo, Lagoas-Marcosende, 36310 Vigo, Spain.
J Med Chem. 2010 Jun 24;53(12):4654-67. doi: 10.1021/jm100244y.
Largazole 4a and analogues with modifications at the C7 position, as well as 2,4'-bithiazole 5a, have been synthesized using an acyclic cross-metathesis of the corresponding depsipeptide structures assembled by N-C6(O) or C15(O)-N lactam formation. Similar to the parent system 4a, the series of largazole depsipeptides 4b-d, but not 2,4'-bithiazole 5a, showed a marked inhibition of recombinant HDAC1 and selectivity over HDAC4, as well as strong pro-apoptotic effects on the NB4 leukemia cell line, but they failed to induce differentiation to mature granulocytes. Functional assays of the analogues correlated with the in vitro activities, as shown by increased H3 and alpha-tubulin acetylation levels and p21(WAF1/CIP1) up-regulation in NB4 cells. The activity of the natural product HDACi largazole 4a is not significantly altered by the presence of groups of different size (H, Et, Ph) at C7 on the dihydrothiazole ring.
已使用相应的去肽结构的非循环交叉复分解反应合成了 largazole 4a 和 C7 位修饰的类似物以及 2,4'-联噻唑 5a,这些去肽结构是通过 N-C6(O)或 C15(O)-N 内酰胺形成组装的。与母体系统 4a 类似, largazole 去肽 4b-d 系列,但不是 2,4'-联噻唑 5a,对重组 HDAC1 表现出明显的抑制作用和对 HDAC4 的选择性,以及对 NB4 白血病细胞系的强烈促凋亡作用,但它们未能诱导成熟粒细胞的分化。类似物的功能测定与体外活性相关,如 NB4 细胞中 H3 和微管蛋白乙酰化水平的增加以及 p21(WAF1/CIP1)的上调所示。天然产物 HDACi largazole 4a 的活性不受 C7 位二氢噻唑环上不同大小(H、Et、Ph)基团的存在显著影响。